[PLX] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
18-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 162.92%
YoY- 164.60%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 8,549 19,495 17,759 27,018 2,469 2,081 -11,195 -
PBT -6,667 397 291 9,781 -15,141 -2,624 -12,419 -9.83%
Tax 908 -212 180 99 916 -189 -85,260 -
NP -6,667 397 291 9,781 -15,141 -2,624 72,900 -
Tax Rate - 53.40% -61.86% -1.01% - - - -
Total Cost 15,216 19,098 17,468 17,237 17,610 4,705 -84,095 -
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -77.99 2.04 1.64 36.20 -613.24 -126.09 -651.18 -29.76%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.15 0.01 0.02 0.66 -1.08 -0.21 7.31 -
EPS Diluted -0.15 0.01 0.02 0.66 -1.04 -0.21 7.31 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.